Underwood Eye Care, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 22 S Beech St, Cortez, CO 81321 Phone: 970-739-6489 |
William Howard Mollenkopf, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 140 N Market St, Cortez, CO 81321 Phone: 970-565-2020 Fax: 970-565-3632 |
Robert Tyler Underwood, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 22 S Beech St, Cortez, CO 81321 Phone: 970-565-7195 |
Dr. Harold Lamar Riegle Jr., O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1835 E Main St, Cortez, CO 81321 Phone: 970-565-9024 |
Kimberly Renee Starnes-parr, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 140 N Market St, Cortez, CO 81321 Phone: 970-565-2020 Fax: 970-565-3632 |
Craig L. Nelson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9 N. Beech St., Cortez, CO 81321 Phone: 970-565-7200 Fax: 970-565-8203 |
Bryce Tanner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 140 North Market St, Cortez, CO 81321 Phone: 970-565-2020 Fax: 970-565-3632 |
Underwood Optical Inc Optometrist Medicare: Medicare Enrolled Practice Location: 22 S Beech St, Cortez, CO 81321 Phone: 970-565-7195 Fax: 970-565-7171 |
Robert D Underwood, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 22 S Beech St, Cortez, CO 81321 Phone: 970-565-7195 Fax: 970-565-7171 |
Cortez Vision Pc Optometrist Medicare: Medicare Enrolled Practice Location: 2423 E Main St Ste 4, Cortez, CO 81321 Phone: 970-565-2020 Fax: 970-565-3632 |
News Archive
Adlyfe, Inc., a privately held biotech company headquartered in Rockville, MD, focused on early diagnostics for animal and human brain diseases announced the award today of a $650,000 two year grant from the Department of Environment, Food and Rural Affairs (DEFRA) in the UK for continued development of a sensitive early blood test for animal prion diseases.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of its planned Phase III registration clinical trial of Epanovaâ„¢, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega 3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Researchers at the Université de Montreal (UdeM) and the Montreal Neurological Institute (MNI), McGill University have discovered that cells which normally support nerve cell (neuron) survival also play an active and major role in the death of neurons in the eye.
Prostate cancer is the second most common type of cancer in men and is predicted to result in an estimated 220,00 cases in the United States in 2015. In recent years, an emphasis has been placed on chemoprevention - the use of agents to prevent the development or progression of prostate cancer.
A unique, high-sensitivity, double surgical glove that saves time and money will be debuted at the Association of Operating Room Nurses (AORN) Congress in San Diego, March 20-25. The glove was developed by Bio-Barrier Inc., an infection control technology company based in Los Angeles. The new glove features two separate layers originating from a single cuff at the wrist.
› Verified 9 days ago